Hiroki Yamaguchi
- Molecular Biology top 10%
- Hematology top 1%
- Physiology top 5%
- Immunology top 5%
- Oncology top 10%
- Co-authors
- Koiti InokuchiNeal S. YoungGabriela M. BaerlocherStephen J. ChanockPeter M. LansdorpSachiko KajigayaHinh LyRodrigo T. Calado
- Topics
- Acute Myeloid Leukemia Research (39 papers)Chronic Myeloid Leukemia Treatments (24 papers)Acute Lymphoblastic Leukemia research (20 papers)
- Cited by
- HematologyAgingGenetics
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hiroki Yamaguchi
182 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Molecular Biology 1.2k
- Hematology 710
- Physiology 626
- Immunology 590
- Oncology 357
Countries citing papers authored by Hiroki Yamaguchi
This map shows the geographic impact of Hiroki Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Yamaguchi more than expected).
Fields of papers citing papers by Hiroki Yamaguchi
This network shows the impact of papers produced by Hiroki Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Yamaguchi. The network helps show where Hiroki Yamaguchi may publish in the future.
Co-authorship network of co-authors of Hiroki Yamaguchi
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Yamaguchi. A scholar is included among the top collaborators of Hiroki Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Yamaguchi. Hiroki Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 7 | |
| 10 | 12 | |
| 11 | 1 | |
| 12 | 11 | |
| 13 | 9 | |
| 14 | 1 | |
| 15 | 0 | |
| 16 | Mitral valve repair for 52 patients with severe left ventricular dysfunction. | 8 |
| 17 | 13 | |
| 18 | 4 | |
| 19 | 0 | |
| 20 | 7 |
About Hiroki Yamaguchi
Hiroki Yamaguchi is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine, having authored 200 papers that have together received 3.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (39 papers), Chronic Myeloid Leukemia Treatments (24 papers) and Acute Lymphoblastic Leukemia research (20 papers). The work is most often cited by research in Hematology (710 citations), Aging (71 citations) and Genetics (352 citations). Hiroki Yamaguchi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Koiti Inokuchi, Neal S. Young, Gabriela M. Baerlocher, Stephen J. Chanock, Peter M. Lansdorp, Sachiko Kajigaya, Hinh Ly, Rodrigo T. Calado, Hirofumi Sawa and Yasuko Orba. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.